Stryker had four patents in advanced materials during Q1 2024. Stryker Corp’s patents in Q1 2024 include an improved shape memory material orthopedic fixation implant for joint fusion procedures, a patient transport apparatus with a non-linear channel for adjusting poses, and a flat embolic braid that can be deployed through a delivery catheter and assumes a twisted configuration in three-dimensional unconstrained state. GlobalData’s report on Stryker gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Stryker grant share with advanced materials as a theme is 25% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Bone fixation implants (Patent ID: US20240058043A1)
The patent filed by Stryker Corp. discloses improved shape memory material orthopedic fixation implants for joint fusion procedures. The implants include a bridge with legs and a metal spacer structure for insertion between bone surfaces, promoting bone ingrowth. The shape memory material allows the bridge to move between an insertion shape and an implanted shape, providing compression in multiple preset directions.
The orthopedic implants also feature additional legs, porous perforated metal spacer structures, and threaded holes for bone screws. The shape memory material used in the implants allows for controlled movement and compression in various directions, enhancing the fusion process. The design variations, such as triangular wedge or trapezoidal shaped profiles, cater to different anatomical needs, making the implants versatile for orthopedic applications.
To know more about GlobalData’s detailed insights on Stryker, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.